As documented previously, tumor microenvironment (TME) played pivotal roles in NSCLC tumorigenesis and drug resistance [36, 37], we therefore examined whether ANKRD29 was involved in the NSCLC TME regulation. The gene discussed is ANKRD29; the disease is neoplasm.